The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles

ApoM is mainly associated with HDL. Nevertheless, we have consistently observed positive correlations of apoM with plasma LDL cholesterol in humans. Moreover, LDL receptor deficiency is associated with increased plasma apoM in mice. Here, we tested the idea that plasma apoM concentrations are affect...

Full description

Bibliographic Details
Main Authors: Christina Christoffersen, Marianne Benn, Pernille M. Christensen, Philip L.S.M. Gordts, Anton J.M. Roebroek, Ruth Frikke-Schmidt, Anne Tybjaerg-Hansen, Björn Dahlbäck, Lars B. Nielsen
Format: Article
Language:English
Published: Elsevier 2012-10-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520431967
id doaj-92644db31c384a0ca91206c9a02f6e51
record_format Article
spelling doaj-92644db31c384a0ca91206c9a02f6e512021-04-28T06:08:09ZengElsevierJournal of Lipid Research0022-22752012-10-01531021982204The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particlesChristina Christoffersen0Marianne Benn1Pernille M. Christensen2Philip L.S.M. Gordts3Anton J.M. Roebroek4Ruth Frikke-Schmidt5Anne Tybjaerg-Hansen6Björn Dahlbäck7Lars B. Nielsen8Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, DenmarkDepartment of Clinical Biochemistry, Herlev University Hospital, Herlev, DenmarkDepartment of Clinical Biochemistry, Rigshospitalet, Copenhagen, DenmarkCenter of Human Genetics, Experimental Mouse Genetics, Katholieke Universiteit, Leuven, BelgiumCenter of Human Genetics, Experimental Mouse Genetics, Katholieke Universiteit, Leuven, BelgiumDepartment of Clinical Biochemistry, Rigshospitalet, Copenhagen, DenmarkDepartment of Laboratory Medicine, Wallenberg Laboratory, Skåne University Hospital, Lund University, Malmö, Sweden; andTo whom correspondence should be addressed. (L.B.N.); (B.D.); Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, DenmarkTo whom correspondence should be addressed. (L.B.N.); (B.D.); Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark; Department of Biomedical Sciences, University of Copenhagen, Copenhagen, DenmarkApoM is mainly associated with HDL. Nevertheless, we have consistently observed positive correlations of apoM with plasma LDL cholesterol in humans. Moreover, LDL receptor deficiency is associated with increased plasma apoM in mice. Here, we tested the idea that plasma apoM concentrations are affected by the rate of LDL receptor-mediated clearance of apoB-containing particles. We measured apoM in humans each carrying one of three different LDL receptor mutations (n = 9) or the apoB3500 mutation (n = 12). These carriers had increased plasma apoM (1.34 ± 0.13 µM, P = 0.003, and 1.23 ± 0.10 µM, P = 0.02, respectively) as compared with noncarriers (0.93 ± 0.04 µM). When we injected human apoM-containing HDL into Wt (n = 6) or LDL receptor-deficient mice (n = 6), the removal of HDL-associated human apoM was delayed in the LDL receptor-deficient mice. After 2 h, 54 ± 5% versus 90 ± 8% (P < 0.005) of the initial amounts of human apoM remained in the plasma of Wt and LDL receptor-deficient mice, respectively. Finally, we compared the turnover of radio-iodinated LDL and plasma apoM concentrations in 45 normocholesterolemic humans. There was a negative correlation between plasma apoM and the fractional catabolic rate of LDL (r =−0.38, P = 0.009). These data suggest that the plasma clearance of apoM, despite apoM primarily being associated with HDL, is influenced by LDL receptor-mediated clearance of apoB-containing particles.http://www.sciencedirect.com/science/article/pii/S0022227520431967lipoproteinlow-density lipoprotein metabolismapolipoproteinfamilial hypercholesterolemia
collection DOAJ
language English
format Article
sources DOAJ
author Christina Christoffersen
Marianne Benn
Pernille M. Christensen
Philip L.S.M. Gordts
Anton J.M. Roebroek
Ruth Frikke-Schmidt
Anne Tybjaerg-Hansen
Björn Dahlbäck
Lars B. Nielsen
spellingShingle Christina Christoffersen
Marianne Benn
Pernille M. Christensen
Philip L.S.M. Gordts
Anton J.M. Roebroek
Ruth Frikke-Schmidt
Anne Tybjaerg-Hansen
Björn Dahlbäck
Lars B. Nielsen
The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles
Journal of Lipid Research
lipoprotein
low-density lipoprotein metabolism
apolipoprotein
familial hypercholesterolemia
author_facet Christina Christoffersen
Marianne Benn
Pernille M. Christensen
Philip L.S.M. Gordts
Anton J.M. Roebroek
Ruth Frikke-Schmidt
Anne Tybjaerg-Hansen
Björn Dahlbäck
Lars B. Nielsen
author_sort Christina Christoffersen
title The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles
title_short The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles
title_full The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles
title_fullStr The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles
title_full_unstemmed The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles
title_sort plasma concentration of hdl-associated apom is influenced by ldl receptor-mediated clearance of apob-containing particles
publisher Elsevier
series Journal of Lipid Research
issn 0022-2275
publishDate 2012-10-01
description ApoM is mainly associated with HDL. Nevertheless, we have consistently observed positive correlations of apoM with plasma LDL cholesterol in humans. Moreover, LDL receptor deficiency is associated with increased plasma apoM in mice. Here, we tested the idea that plasma apoM concentrations are affected by the rate of LDL receptor-mediated clearance of apoB-containing particles. We measured apoM in humans each carrying one of three different LDL receptor mutations (n = 9) or the apoB3500 mutation (n = 12). These carriers had increased plasma apoM (1.34 ± 0.13 µM, P = 0.003, and 1.23 ± 0.10 µM, P = 0.02, respectively) as compared with noncarriers (0.93 ± 0.04 µM). When we injected human apoM-containing HDL into Wt (n = 6) or LDL receptor-deficient mice (n = 6), the removal of HDL-associated human apoM was delayed in the LDL receptor-deficient mice. After 2 h, 54 ± 5% versus 90 ± 8% (P < 0.005) of the initial amounts of human apoM remained in the plasma of Wt and LDL receptor-deficient mice, respectively. Finally, we compared the turnover of radio-iodinated LDL and plasma apoM concentrations in 45 normocholesterolemic humans. There was a negative correlation between plasma apoM and the fractional catabolic rate of LDL (r =−0.38, P = 0.009). These data suggest that the plasma clearance of apoM, despite apoM primarily being associated with HDL, is influenced by LDL receptor-mediated clearance of apoB-containing particles.
topic lipoprotein
low-density lipoprotein metabolism
apolipoprotein
familial hypercholesterolemia
url http://www.sciencedirect.com/science/article/pii/S0022227520431967
work_keys_str_mv AT christinachristoffersen theplasmaconcentrationofhdlassociatedapomisinfluencedbyldlreceptormediatedclearanceofapobcontainingparticles
AT mariannebenn theplasmaconcentrationofhdlassociatedapomisinfluencedbyldlreceptormediatedclearanceofapobcontainingparticles
AT pernillemchristensen theplasmaconcentrationofhdlassociatedapomisinfluencedbyldlreceptormediatedclearanceofapobcontainingparticles
AT philiplsmgordts theplasmaconcentrationofhdlassociatedapomisinfluencedbyldlreceptormediatedclearanceofapobcontainingparticles
AT antonjmroebroek theplasmaconcentrationofhdlassociatedapomisinfluencedbyldlreceptormediatedclearanceofapobcontainingparticles
AT ruthfrikkeschmidt theplasmaconcentrationofhdlassociatedapomisinfluencedbyldlreceptormediatedclearanceofapobcontainingparticles
AT annetybjaerghansen theplasmaconcentrationofhdlassociatedapomisinfluencedbyldlreceptormediatedclearanceofapobcontainingparticles
AT bjorndahlback theplasmaconcentrationofhdlassociatedapomisinfluencedbyldlreceptormediatedclearanceofapobcontainingparticles
AT larsbnielsen theplasmaconcentrationofhdlassociatedapomisinfluencedbyldlreceptormediatedclearanceofapobcontainingparticles
AT christinachristoffersen plasmaconcentrationofhdlassociatedapomisinfluencedbyldlreceptormediatedclearanceofapobcontainingparticles
AT mariannebenn plasmaconcentrationofhdlassociatedapomisinfluencedbyldlreceptormediatedclearanceofapobcontainingparticles
AT pernillemchristensen plasmaconcentrationofhdlassociatedapomisinfluencedbyldlreceptormediatedclearanceofapobcontainingparticles
AT philiplsmgordts plasmaconcentrationofhdlassociatedapomisinfluencedbyldlreceptormediatedclearanceofapobcontainingparticles
AT antonjmroebroek plasmaconcentrationofhdlassociatedapomisinfluencedbyldlreceptormediatedclearanceofapobcontainingparticles
AT ruthfrikkeschmidt plasmaconcentrationofhdlassociatedapomisinfluencedbyldlreceptormediatedclearanceofapobcontainingparticles
AT annetybjaerghansen plasmaconcentrationofhdlassociatedapomisinfluencedbyldlreceptormediatedclearanceofapobcontainingparticles
AT bjorndahlback plasmaconcentrationofhdlassociatedapomisinfluencedbyldlreceptormediatedclearanceofapobcontainingparticles
AT larsbnielsen plasmaconcentrationofhdlassociatedapomisinfluencedbyldlreceptormediatedclearanceofapobcontainingparticles
_version_ 1721504039521222656